Obalon Schedules Third Quarter 2019 Financial Results Conference Call for November 8, 2019 at 9:00 a.m. Eastern Time
October 31 2019 - 7:15AM
Obalon Therapeutics, Inc. (NASDAQ: OBLN), a weight loss solutions
company with the first and only FDA-approved swallowable,
gas-filled intragastric balloon system for the treatment of
obesity, announces that it plans to release its third quarter
2019 financial results before the market opens on Friday, November
8, 2019 and hold a conference call at 9:00 AM Eastern Time (6:00 AM
Pacific Time) to discuss the Company's financial results and
provide a business update. Interested parties may access the
conference call by dialing (844) 889-7791 (U.S.) or (661) 378-9934
(international) using passcode 4987828. Media and individuals will
be in a listen-only mode. Participants are asked to dial in a few
minutes prior to the call to register for the event. The conference
call will also be webcast live at:
https://edge.media-server.com/mmc/p/htzhm89b
An archive of the webcast will be available for twelve months
following the event on the Obalon Therapeutics website located at
http://investor.obalon.com in the “News & Events”
section.
About Obalon Therapeutics, Inc. Obalon
Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company
focused on developing and commercializing novel technologies for
weight loss. For more information, please
visit www.obalon.com.
For Obalon Therapeutics, Inc.
Investor Contact:William PlovanicPresident & Chief Executive
OfficerObalon Therapeutics, Inc.Office: +1 760 607
5103wplovanic@obalon.com
Obalon Therapeutics (NASDAQ:OBLN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Obalon Therapeutics (NASDAQ:OBLN)
Historical Stock Chart
From Sep 2023 to Sep 2024